Edited By: Dr Robert J. Boyle and Prof Mohamed H. Shamji
Journal list menu
Clinical & Experimental Allergy is the official Journal of the British Society for Allergy & Clinical Immunology, publishing clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field.
On the Cover
Articles
Association of Abnormal Body Weight and Allergic Rhinitis—A Systematic Review and Meta‐Analysis
-  27 November 2024
One Year of Oral Immunotherapy Impacts the Gut Microbiota and Plasma Metabolome of Peanut‐Allergic Young Children
-  27 November 2024
Caesarean Section and Atopic Dermatitis Risk: Insights From a Nationwide, Population‐Based Cohort Study
-  26 November 2024
Alternatives to Injectable Adrenaline for Treating Anaphylaxis
-  24 November 2024
Graphical Abstract
New developments in the treatment of anaphylaxis: alternative forms of administration of adrenaline other than by injection. Given barriers to the use of adrenaline auto-injectors, alternative forms of adrenaline are desirable. Several devices using adrenaline by intranasal, sublingual or transcutaneous route are currently under investigation. An adrenaline intranasal spray for anaphylaxis treatment is now approved in the United States and Europe.
Milk Component IgE/IgG4 Levels for Diagnosis of Cow Milk Protein Allergy in Sensitised Children—A Diagnostic Test Accuracy Study
-  24 November 2024
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study
- Clinical & Experimental Allergy
-  337-352
-  8 February 2023
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
- Clinical & Experimental Allergy
-  156-172
-  18 January 2023
From trained immunity in allergy to trained immunity-based allergen vaccines
- Clinical & Experimental Allergy
-  145-155
-  9 December 2022
Population prevalence of allergic bronchopulmonary aspergillosis in asthma: An epidemiological study of 43,261 participants from North India
- Clinical & Experimental Allergy
-  777-780
-  21 February 2023
The impact of prenatal dog keeping on infant gut microbiota development
- Clinical & Experimental Allergy
-  833-845
-  14 March 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series
- Clinical & Experimental Allergy
-  586-589
-  16 March 2023
Oral immunotherapy using boiled peanuts for treating peanut allergy: An open‐label, single‐arm trial
- Clinical & Experimental Allergy
-  327-336
-  11 January 2023
House dust mite components sensitization profile in China, a multi‐centre study
- Clinical & Experimental Allergy
-  226-229
-  15 December 2022
Health‐related quality of life in food and venom induced anaphylaxis and role of influencing factors
- Clinical & Experimental Allergy
-  295-306
-  23 December 2022
Epigenome alterations in food allergy: A systematic review of candidate gene and epigenome-wide association studies
- Clinical & Experimental Allergy
-  259-275
-  9 February 2023
BabyBathe study protocol: A randomised controlled feasibility trial to change baby bathing practice during the first months of life
- Clinical & Experimental Allergy
-  353-355
-  10 March 2024
Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study
- Clinical & Experimental Allergy
-  337-352
-  8 February 2023
Management of Refractory Anaphylaxis: An Overview of Current Guidelines
- Clinical & Experimental Allergy
-  470-488
-  12 June 2024
Allergic diseases as risk factors for Long-COVID symptoms: Systematic review of prospective cohort studies
- Clinical & Experimental Allergy
-  1162-1176
-  8 November 2023
Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series
- Clinical & Experimental Allergy
-  586-589
-  16 March 2023
Anaphylaxis mortality in the perioperative setting: Epidemiology, elicitors, risk factors and knowledge gaps
- Clinical & Experimental Allergy
-  11-20
-  2 January 2024
Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies
- Clinical & Experimental Allergy
-  582-585
-  13 February 2023
Role of IL-5 in asthma and airway remodelling
- Clinical & Experimental Allergy
-  538-549
-  27 June 2024
Effectiveness of FeNO-guided treatment in adult asthma patients: A systematic review and meta-analysis
- Clinical & Experimental Allergy
-  798-808
-  9 June 2023
Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma
- Clinical & Experimental Allergy
-  265-277
-  22 January 2024
Recent issues
- Volume 54, Issue 11
Special Issue: Nutrition and Allergy
i, 849-945November 2024Vanessa Garcia Larssen, Isabel Skypala